Author: Manish Tiwari; Divya Mishra
Title: Investigating the genomic landscape in novel coronavirus (2019-nCoV) genomes to identify non-synonymous mutations for use in diagnosis and drug design Document date: 2020_4_18
ID: f0z8gcws_27
Snippet: In conclusion, present study enlightens about several types of mutation such as deletion, insertion and substitutions present in 2019-nCoV samples. These mutations may vary at different geographical distribution or interaction with different host systems. Few mutations also resulted in change of amino acid which may provide an explanation for failure of previously employed antiviral therapies. This research will better equip the researchers to ut.....
Document: In conclusion, present study enlightens about several types of mutation such as deletion, insertion and substitutions present in 2019-nCoV samples. These mutations may vary at different geographical distribution or interaction with different host systems. Few mutations also resulted in change of amino acid which may provide an explanation for failure of previously employed antiviral therapies. This research will better equip the researchers to utilize the mutated amino acid information for drug targets in particular geography and less cases of failure. Beside the substitution resulting into transformation to a more virulent strain there are number of highly conserved regions in the hCoV genome which can be used as target for inhibitory drugs and vaccine development for a large repertoire of strains. Finally, author/funder. All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- amino acid and different geographical distribution: 1
- amino acid and drug target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- amino acid and failure case: 1
- amino acid and geographical distribution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amino acid and hCoV genome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amino acid and host system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- amino acid and inhibitory drug: 1, 2, 3
- amino acid and large repertoire: 1
- amino acid and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- amino acid and substitution insertion: 1, 2, 3, 4
- amino acid and substitution insertion deletion: 1, 2
- amino acid and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- amino acid and virulent strain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- amino acid change and drug target: 1, 2, 3
- amino acid change and failure case: 1
- amino acid change and present study: 1
- amino acid change and vaccine development: 1, 2, 3, 4, 5
- amino acid change and virulent strain: 1
- amino acid information and drug target: 1
Co phrase search for related documents, hyperlinks ordered by date